Mandatum Life Insurance Company’s Target TGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.42M | Hold |
44,723
| – | – | 1.22% | 21 |
|
|
2025
Q4 | $4.37M | Hold |
44,723
| – | – | 1% | 24 |
|
|
2025
Q3 | $4.01M | Buy |
44,723
+7,000
| +19% | +$689K | 0.96% | 25 |
|
|
2025
Q2 | $3.72M | Hold |
37,723
| – | – | 0.98% | 25 |
|
|
2025
Q1 | $3.94M | Buy |
37,723
+5,000
| +15% | +$625K | 1.21% | 23 |
|
|
2024
Q4 | $4.42M | Hold |
32,723
| – | – | 1.31% | 17 |
|
|
2024
Q3 | $5.1M | Hold |
32,723
| – | – | 1.56% | 16 |
|
|
2024
Q2 | $4.84M | Hold |
32,723
| – | – | 1.62% | 15 |
|
|
2024
Q1 | $5.8M | Hold |
32,723
| – | – | 1.94% | 10 |
|
|
2023
Q4 | $4.66M | Hold |
32,723
| – | – | 1.73% | 13 |
|
|
2023
Q3 | $3.62M | Buy |
32,723
+4,000
| +14% | +$508K | 1.51% | 15 |
|
|
2023
Q2 | $3.79M | Hold |
28,723
| – | – | 1.57% | 16 |
|
|
2023
Q1 | $4.76M | Hold |
28,723
| – | – | 1.4% | 11 |
|
|
2022
Q4 | $4.28M | Buy |
28,723
+2,723
| +10% | +$427K | 1.3% | 16 |
|
|
2022
Q3 | $3.86M | Hold |
26,000
| – | – | 1.23% | 13 |
|
|
2022
Q2 | $3.67M | Buy |
26,000
+2,000
| +8% | +$383K | 0.82% | 18 |
|
|
2022
Q1 | $5.09M | Hold |
24,000
| – | – | 0.94% | 15 |
|
|
2021
Q4 | $5.55M | Hold |
24,000
| – | – | 1.47% | 13 |
|
|
2021
Q3 | $5.49M | Hold |
24,000
| – | – | 1.02% | 31 |
|
|
2021
Q2 | $5.8M | Hold |
24,000
| – | – | 1.05% | 29 |
|
|
2021
Q1 | $4.75M | Hold |
24,000
| – | – | 0.94% | 36 |
|
|
2020
Q4 | $4.24M | Buy |
24,000
+3,620
| +18% | +$604K | 0.88% | 39 |
|
|
2020
Q3 | $3.21M | Hold |
20,380
| – | – | 0.71% | 42 |
|
|
2020
Q2 | $2.44M | Sell |
20,380
-3,581
| -15% | -$409K | 0.59% | 45 |
|
|
2020
Q1 | $2.23M | Buy |
23,961
+9,088
| +61% | +$1.01M | 0.6% | 47 |
|
|
2019
Q4 | $1.91M | Sell |
14,873
-480
| -3% | -$56.3K | 0.4% | 66 |
|
|
2019
Q3 | $1.64M | Buy |
15,353
+530
| +4% | +$50.4K | 0.33% | 65 |
|
|
2019
Q2 | $1.28M | Buy |
14,823
+2,544
| +21% | +$206K | 0.27% | 74 |
|
|
2019
Q1 | $986K | Buy |
12,279
+751
| +7% | +$54.9K | 0.21% | 81 |
|
|
2018
Q4 | $762K | Buy |
11,528
+3,580
| +45% | +$275K | 0.18% | 91 |
|
|
2018
Q3 | $701K | Buy |
7,948
+858
| +12% | +$71.4K | 0.13% | 91 |
|
|
2018
Q2 | $540K | Buy |
7,090
+180
| +3% | +$13.2K | 0.1% | 99 |
|
|
2018
Q1 | $480K | Sell |
6,910
-1,143
| -14% | -$83.2K | 0.09% | 100 |
|
|
2017
Q4 | $525K | Hold |
8,053
| – | – | 0.08% | 121 |
|
|
2017
Q3 | $475K | Sell |
8,053
-2,515
| -24% | -$141K | 0.06% | 129 |
|
|
2017
Q2 | $553K | Sell |
10,568
-1,774
| -14% | -$96.9K | 0.08% | 120 |
|
|
2017
Q1 | $681K | Buy |
12,342
+6,450
| +109% | +$401K | 0.09% | 127 |
|
|
2016
Q4 | $426K | Buy |
5,892
+1,481
| +34% | +$107K | 0.06% | 155 |
|
|
2016
Q3 | $303K | Hold |
4,411
| – | – | 0.04% | 170 |
|
|
2016
Q2 | $308K | Hold |
4,411
| – | – | 0.04% | 171 |
|
|
2016
Q1 | $363K | Hold |
4,411
| – | – | 0.05% | 150 |
|
|
2015
Q4 | $320K | Buy |
+4,411
| New | +$329K | 0.04% | 170 |
|
Other funds holding TGT
VCM
VPM
Mandatum Life Insurance Company's TGT Position: Q1 2026 in Review
Mandatum Life Insurance Company held its Target (TGT) position steady in Q1 2026 at 44,723 shares worth $5.42M. The position accounts for 1.22% of the portfolio, ranked #21.
Mandatum Life Insurance Company first reported a position in TGT in Q4 2015 and has held it in 42 quarters since. The position peaked at $5.8M in Q2 2021. 1,842 funds tracked by Wall St. Rank hold TGT as of Q1 2026.
- Mandatum Life Insurance Company held 44,723 shares of Target worth $5.42M as of Q1 2026.
- Mandatum Life Insurance Company left its Target share count unchanged in Q1 2026.
- Target made up 1.22% of Mandatum Life Insurance Company's portfolio in Q1 2026, its #21 holding.
- Mandatum Life Insurance Company first reported a position in Target in Q4 2015 and has held it in 42 quarters since.
- Mandatum Life Insurance Company's Target position peaked at $5.8M in Q2 2021.
- 1,842 funds tracked by Wall St. Rank held Target as of Q1 2026.
Based on Mandatum Life Insurance Company's 13F filing for Q1 2026, filed 5 May 2026.